PHPBiotech.wikiThe PHP Biotech Reference

Leadership and team

From PHPBiotech.wiki, a sourced reference on PHP Biotech, a preclinical oncology company

Short answer: PHP Biotech lists Robert Gahagen as chief executive officer, Eduardo Motti, MD, as chief operating officer, João Marcelo Carucci as chief financial officer and Patrícia Bezerra, PhD, as head of research and development; founder Moacyr Bighetti sits on its executive committee.[1][2]

Disclosure: PHPBiotech.wiki is a reference compiled from public sources. It is not the official website of PHP Biotech International Inc.; it is produced by a marketing agency that works for PHP Biotech. It is not written or reviewed by the U.S. Food and Drug Administration or any other regulator, by the journal that published the company’s research, or by any patent office. Nothing on this site is medical advice. PHP53-nb is an investigational, preclinical product: it is not approved for any use and is not available to patients. Facts are cited to public registries, PubMed, patent records, archived web pages, press releases and the company’s own website. See the editorial policy.

Who leads PHP Biotech?

Leadership team
NameRole (company website)
Robert GahagenChief Executive Officer
Eduardo Motti, MDChief Operating Officer
João Marcelo CarucciChief Financial Officer
Patrícia Bezerra, PhDHead of Research & Development

Source: the company’s team page.[1]

Who is on the executive committee and advisory board?

Executive Committee
NameRole (company website)
Moacyr BighettiFounder; Co-Founder & Executive Committee
Oswaldo Bighetti NetoExecutive Committee Member
Eduardo Braun, MDExecutive Committee Member
Paulo NigroExecutive Committee Member
Advisory Board
NameRole (company website)
Antonio Carlos Buzaid, MDAdvisory Board Member
Fabio A. Jung, MDAdvisory Board Member
Jorge Brasil, MDAdvisory Board Member
Kleber MirandaAdvisory Board Member

Source: the company’s team and About pages.[1][2]

Who founded PHP Biotech?

The company names Moacyr Bighetti as its founder.[1][3] He is a named inventor on both published patent applications, and Brazil’s federal tax registry lists Moacyr Ramos Bighetti as president of PHP Biotech Pesquisa e Desenvolvimento S.A.[4][5][6] The chief financial officer’s biography says the FCJ Venture Builder “partnered in PHP Biotech’s founding”.[7]

Which roles are confirmed outside the company website?

Patrícia Bezerra and Eduardo Motti are the authors of the 2024 Molecules paper, which states they are employed by PHP Biotech International Inc.[8] Bighetti and Bezerra are the inventors on both patent applications.[4][5] Six people on the company roster also appear on the Brazilian registry record: Moacyr Ramos Bighetti, Eduardo Franco Motti, João Marcelo Carucci de Souza, Kleber Oliveira Miranda, Oswaldo Bighetti Neto and Jorge Luiz Brasil Siqueira.[6] Career details in the biographies are the company’s own descriptions and were not checked against outside records.

Do press releases give the same titles?

Not always. A press release dated 25 September 2026 calls Moacyr Bighetti “Founder and Chairman”, Eduardo Braun a “Board Member” and Fabio Jung a “Partner at Synchro”, and names “Prof. Marcelo Baruffi, PhD, nanobody scientist”, who does not appear on the company website.[9] The website lists Jung as an advisory board member whose biography says he is a senior advisor at Boston Consulting Group.[1][10] The current titles are an open question.

Who has invested in PHP Biotech?

The company has not published a list of investors. One advisory board member’s biography describes him as “an investor in PHP Biotech”.[11] No SEC filings, including Form D notices of private offerings, were found for PHP Biotech.[12] Funding is an open question.

Frequently asked questions

Who is the CEO of PHP Biotech?

Robert Gahagen, according to the company website.

Who founded PHP Biotech?

Moacyr Bighetti, according to the company. He is also a named inventor on its patent applications.

Who leads research at PHP Biotech?

Patrícia Bezerra, PhD, head of research and development and first author of the 2024 3-NAntC paper.

See also

References

  1. ^ a b c d e “Our Team”. PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  2. ^ a b “About Us”. PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  3. ^ “Moacyr Bighetti” (biography). PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  4. ^ a b US 2023/0364204 A1, “Bioactive Peptides, Compositions, Production Process, and Use of Bioactive Peptides as Anti-Tumoral Agents” (application 18/313,141). Google Patents (U.S. Patent and Trademark Office data). Retrieved 4 October 2026.
  5. ^ a b US 2026/0041783 A1, “Nanobody platform, Peptide-modified Nanobody, Production Process, and Use” (application 19/223,678). Google Patents (U.S. Patent and Trademark Office data). Retrieved 4 October 2026.
  6. ^ a b CNPJ 40.622.810/0001-02: PHP Biotech Pesquisa e Desenvolvimento S.A. (company registration record). Receita Federal do Brasil, via the BrasilAPI CNPJ service. Retrieved 4 October 2026.
  7. ^ “João Marcelo Carucci” (CFO biography). PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  8. ^ Bezerra P, Motti EF. “3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 Breast Cancer Cell Line.” Molecules 2024;29(7):1646. doi:10.3390/molecules29071646. PMID 38611925. PubMed, U.S. National Library of Medicine. Retrieved 4 October 2026.
  9. ^ “PHP Biotech to Present Nanobody Panel and Sponsor 3rd Annual Oncology Venture, Innovation & Partnering Summit” (25 September 2026). PressAdvantage newsroom (company press release). Retrieved 4 October 2026.
  10. ^ “Fabio A. Jung” (biography). PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  11. ^ “Kleber Miranda” (biography). PHP Biotech International Inc. (phpbiotech.com). Retrieved 4 October 2026.
  12. ^ EDGAR company and full-text search for “PHP Biotech” (no filings found). U.S. Securities and Exchange Commission. Retrieved 4 October 2026.